Cargando…
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy
APOBEC3B, an anti-viral cytidine deaminase which induces DNA mutations, has been implicated as a mediator of cancer evolution and therapeutic resistance. Mutational plasticity also drives generation of neoepitopes, which prime anti-tumor T cells. Here, we show that overexpression of APOBEC3B in tumo...
Autores principales: | Driscoll, Christopher B., Schuelke, Matthew R., Kottke, Timothy, Thompson, Jill M., Wongthida, Phonphimon, Tonne, Jason M., Huff, Amanda L., Miller, Amber, Shim, Kevin G., Molan, Amy, Wetmore, Cynthia, Selby, Peter, Samson, Adel, Harrington, Kevin, Pandha, Hardev, Melcher, Alan, Pulido, Jose S., Harris, Reuben, Evgin, Laura, Vile, Richard G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005822/ https://www.ncbi.nlm.nih.gov/pubmed/32034147 http://dx.doi.org/10.1038/s41467-020-14568-7 |
Ejemplares similares
-
APOBEC3 Mediates Resistance to Oncolytic Viral Therapy
por: Huff, Amanda L., et al.
Publicado: (2018) -
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors
por: Wongthida, Phonphimon, et al.
Publicado: (2020) -
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy
por: Kottke, Timothy, et al.
Publicado: (2021) -
Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity
por: Schuelke, Matthew R., et al.
Publicado: (2019) -
Broad Antigenic Coverage Induced by Viral cDNA Library-based Vaccination Cures Established Tumors
por: Kottke, Timothy, et al.
Publicado: (2011)